Skip to content

Ethanol-induced cellular metastable state sensitization for copper-based oxidative tumor therapy.

Sep 2026 · Biomaterials · Vol 338 Pt A, pp. 124610 · 0 citations · 47 references
Medicine

TL;DR

An ethanol-induced metastable state modulation strategy to sensitize copper-based tumor therapy and advances the application of metal alkoxides in cancer treatment are introduced.

Abstract

Ethanol-induced intracellular reactive oxygen species storm offers inspiration for oxidative tumor therapy. Although ethanol-based treatments provide benefits such as affordability and low toxicity, their safety and therapeutic efficiency still face challenges. Herein, we develop a polyethylene glycol-stabilized nano-sized copper ethoxide (Nano-CuEOP), enabling safe and efficient ethanol delivery. Upon endocytosis by melanoma cells, Nano-CuEOP releases ethanol and transforms into nano-copper oxide aggregates (Nano-HCuEO). The ethanol-induced "sub-toxic" effect upregulates the expression of intracellular cytochrome P450 2E1, driving the cells into a metastable state with heightened susceptibility to transition metals. This, in turn, enhances the catalytic activity and copper ion toxicity of Nano-HCuEO. A single intratumoral Nano-CuEOP injection achieves efficient melanoma treatment and remolds the immune microenvironment. Combined with αPD-1, the system triggers a strong systemic anti-tumor response. This study introduces an ethanol-induced metastable state modulation strategy to sensitize copper-based tumor therapy and advances the application of metal alkoxides in cancer treatment.

View source

Similar papers

Sep 2026

Tumor microenvironment-responsive micelles for mitochondrial copper depletion to enhance photodynamic therapy.

Triple-negative breast cancer (TNBC) exhibits aberrant copper accumulation that promotes tumor progression and metastasis. Targeting copper homeostasis, particularly at the mitochondrial level, represents a promising yet underexplored therapeutic strategy. Herein, a mitochondria-targeted nano-micellar system Ce6-TPP@PS...

Li-Li Chen, Zi-Hui Yan, Yongzhu Hu et al. · 0 citations
Review Open access Aug 2026

Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects

Hydrogen is employed as a therapeutic gas in the treatment of stroke, tissue repair, and cancer, owing to its excellent biocompatibility, antioxidant properties, anti-inflammatory effects, and regulation of cellular metabolism. Moreover, nanometallic materials generate hydrogen through pH-responsive, light-responsive,...

Yuxuan Ding, Min Ma, Jia-Ning Wang et al. · 0 citations
Open access Sep 2026

Organic Nanozyme‐Embedded Biotherapeutic Thermosensitive Hydrogel for Extracellular GSH Depletion and Postoperative Tumor Suppression

A multifunctional hydrogel loaded with a novel cyanine nanozyme and Escherichia coli combines efficient photothermal therapy, photodynamic therapy, and peroxidase‐like enzyme activity to provide a novel and effective strategy for postoperative tumor therapy and recurrence inhibition.

Cong Jiang, Zi-Fan Yang, Rong Guo et al. · 0 citations
Sep 2026

Nanozyme-Driven Tumor Microenvironment Remodeling for Potentiated Phototherapy–Immunotherapy

A multifunctional manganese-based nanozyme loaded with indocyanine green (ICG) is developed to reprogram the immunosuppressive TME for potentiated phototherapy combined with immunotherapy and elicits robust immune memory to prevent recurrence and metastasis.

Chen-Lu Huang, Han-Yong Wang, Xin-Yu Yang et al. · 0 citations
#protein folding Sep 2026

Cysteine-Inspired Photosensitizer with Efficient Tumor Accumulation Enables Thermoresistance Reversal for Reciprocal Enhancement of Photodynamic-Photothermal Therapy.

A cysteine-inspired conjugated polymer photosensitizer was developed to integrate enhanced tumor accumulation, hydrogen sulfide generation, photodynamic therapy (PDT), and photothermal therapy (PTT), achieving an 89% tumor inhibition rate without detectable skin injury or systemic toxicity.

Yan Yuan, Zhi-Jie Fang, Wei-Qing Yue et al. · 0 citations
Aug 2026

Polyphenol-engineered selenium nanocatalysts enable neuroprotective glioblastoma chemoimmunotherapy via nose-to-brain delivery.

Glioblastoma therapy is severely limited by poor blood-brain barrier (BBB) penetration and systemic toxicity of chemotherapeutics. Here, we engineered polyphenol-stabilized selenium nanoparticles (nGPSe NPs, <60 nm) via spatial confinement synthesis as a redox-dual nanocatalytic carrier for afatinib (AFA). These AFA@nG...

Shunming Hong, Rong Hu, Qing-Bin Nie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.